Cancer News: Testicular
Cisplatin treatment is to blame for the hearing loss of many testicular cancer survivors, researchers report.
Scientists comparing treatment methods for stage II testicular cancer report that radiotherapy is more effective than chemotherapy.
A new test can detect for which testicular cancer patients surveillance would be the best choice, sparing them from the side-effects of chemotherapy.
A study of 180,000 men indicates that men with history of testicular cancer have much higher risk of prostate cancer.
Researchers reveal new genetic mutations that could drive testicular cancer, and a gene which may contribute to resistance to drugs against the disease.
Researchers have identified a genetic variant which is associated with a very large risk of testicular cancer. This may lead to new personalized treatments.